- Home
- EMF vs SMTI Comparison
EMF vs SMTI Comparison
Compare EMF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMF
- SMTI
- Stock Information
- Founded
- EMF 1987
- SMTI 1982
- Country
- EMF United States
- SMTI United States
- Employees
- EMF N/A
- SMTI N/A
- Industry
- EMF Finance/Investors Services
- SMTI Medical/Dental Instruments
- Sector
- EMF Finance
- SMTI Health Care
- Exchange
- EMF Nasdaq
- SMTI Nasdaq
- Market Cap
- EMF 254.5M
- SMTI 251.6M
- IPO Year
- EMF N/A
- SMTI N/A
- Fundamental
- Price
- EMF $17.72
- SMTI $28.04
- Analyst Decision
- EMF
- SMTI Strong Buy
- Analyst Count
- EMF 0
- SMTI 2
- Target Price
- EMF N/A
- SMTI $50.00
- AVG Volume (30 Days)
- EMF 29.3K
- SMTI 22.3K
- Earning Date
- EMF 01-01-0001
- SMTI 11-12-2025
- Dividend Yield
- EMF 6.16%
- SMTI N/A
- EPS Growth
- EMF N/A
- SMTI N/A
- EPS
- EMF N/A
- SMTI N/A
- Revenue
- EMF N/A
- SMTI $97,241,894.00
- Revenue This Year
- EMF N/A
- SMTI $24.49
- Revenue Next Year
- EMF N/A
- SMTI $14.43
- P/E Ratio
- EMF N/A
- SMTI N/A
- Revenue Growth
- EMF N/A
- SMTI 34.29
- 52 Week Low
- EMF $10.58
- SMTI $23.53
- 52 Week High
- EMF $12.67
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- EMF 65.21
- SMTI 39.27
- Support Level
- EMF $16.82
- SMTI $28.30
- Resistance Level
- EMF $18.01
- SMTI $29.39
- Average True Range (ATR)
- EMF 0.27
- SMTI 1.22
- MACD
- EMF 0.04
- SMTI -0.13
- Stochastic Oscillator
- EMF 77.39
- SMTI 1.18
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.